Clinical Management of Multidrug-Resistant Pulmonary Tuberculosis in Geriatric: A Case Study at RSUD Prof. Dr. Aloei Saboe
DOI:
https://doi.org/10.53861/lontarariset.v7i1.644Keywords:
Clinical Management, Drug Related Problem, Geriatric, Multidrug-resistant tuberculosisAbstract
Drug-resistant pulmonary tuberculosis (DR-TB) is a challenging form of TB characterized by resistance to at least rifampicin and isoniazid, requiring the use of complex second-line therapies. This condition is often accompanied by complications that further aggravate the clinical course. The aim of this study was to evaluate the management of DR-TB with complications. This retrospective case study was based on the medical record of a 63-year-old female patient with a history of TB in 2020 who was diagnosed with relapsed DR-TB complicated by hypertension, anemia, and insomnia. The diagnosis was confirmed through a rapid molecular test showing a positive result for Mycobacterium tuberculosis with rifampicin resistance. Initial management included the administration of second-line antibiotics, blood transfusion to address anemia, and supportive care for accompanying symptoms. Following two consecutive positive results, the patient commenced second-line anti-tuberculosis (ATT) therapy according to MDR-TB treatment standards. Evaluation revealed improvement in hemoglobin levels after transfusion, although shortness of breath persisted and required further monitoring. In conclusion, the management of DR-TB with complications requires a multidisciplinary approach tailored to the patient’s clinical condition
Downloads
References
Abay, F., Yalew, A., Shibabaw, A., & Enawgaw, B. (2018). Hematological Abnormalities of Pulmonary Tuberculosis Patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study. Tuberculosis Research and Treatment, 2018, 1–6. https://doi.org/10.1155/2018/5740951
Admassu, F., Abera, E., & Gizechew, A. (2022). Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. BMJ Open, 1–6.
Devina Esmeralda, N., & Amelia Chozie, N. (2015). Laporan kasus berbasis bukti Efektivitas Premedikasi untuk Pencegahan Reaksi Transfusi Evidence base case report Effectiveness of Premedication in Preventing Blood Transfusion Reaction (Vol. 17, Issue 4).
Dinas Kesehatan Provinsi Gorontalo. (2021). Analisis Determinan Kejadian Tuberkulosis: Data Wilayah Kerja Puskesmas Tilango, Kabupaten Gorontalo.
Fei, C. M., Zainal, H., & Hyder Ali, I. A. (2018). Evaluation of adverse reactions induced by anti-tuberculosis drugs in hospital Pulau Pinang. Malaysian Journal of Medical Sciences, 25(5), 103–114. https://doi.org/10.21315/mjms2018.25.5.10
Herawati, C., Nur Abdurakhman, R., Rundamintasih, N., & Studi Kesehatan Masyarakat Sekolah Tinggi Ilmu Kesehatan Cirebon, P. (2020). Peran Dukungan Keluarga, Petugas Kesehatan dan Perceived Stigma dalam Meningkatkan Kepatuhan Minum Obat pada Penderita Tuberculosis Paru. In Jurnal Kesehatan Masyarakat Indonesia (Vol. 15, Issue 1). https://jurnal.unimus.ac.id/index.php/jkmi
Intan Setiani, N., Fajarini, H., Ferry Balfas, R., Studi DIII Farmasi, P., Ilmu Kesehatan, F., Muhadi Setiabudi, U., Brebes, K., & Jawa Tengah, P. (2023). MOTEKAR: Jurnal Multidisiplin Teknologi dan Arsitektur Pola Penggunaan Obat Tuberkulosis Resisten Obat pada Pasien Rawat Inap di Rumah Sakit Umum Daerah Brebes. Novita Intan Setiani, 1(2).
Jaryah Bahrir, A. (2019). Penyalahgunaan Obat Kodein dan Tahapan Pembuktiannya: Tiga Laporan Kasus Codeine-Associated Drug Abuse and How The Investigation Stages: Three Case Report.
Kementerian Kesehatan RI. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Kementrian Kesehatan Republik Indonesia.
Lange, C., Dheda, K., Chesov, D., Mandalakas, A. M., Udwadia, Z., & Horsburgh, R. (2019). Management of drug-resistant tuberculosis. In www.thelancet.com (Vol. 394). www.thelancet.com/
Maulidar, R., Nurjannah, N., Adamy, A., & Iskandar, I. (2021). Pengaruh Pemberian Obat Anti Tuberkulosis Dengan Vitamin D Terhadap Perubahan BTA Pada Penderita Tuberkulosis Paru Di Kabupaten Pidie. Jurnal SAGO Gizi Dan Kesehatan, 2(1), 25. https://doi.org/10.30867/gikes.v2i1.442
Mocan, M., & Blaga, S. N. (2016). Severe Hyponatremia due to Levofloxacin Treatment for Pseudomonas aeruginosa Community-Acquired Pneumonia in a Patient with Oropharyngeal Cancer. Case Reports in Medicine, 2016. https://doi.org/10.1155/2016/5434230
Puspita, A. F., & Nurchayati, S. (2024). Hubungan Lama Pengobatan Dengan Tingkat Depresi Pada Pasien TB MDR.
Radiah, N., Arista Pratama, I., & Pahmi, K. (2023). Studi Penggunaan NSAID (Nonsteroidal Anti Inflamantory Drugs) Pasien Osteoarthritis Usia Lanjut di Rumah Sakit X Sumbawa Barat. Journal Syifa Sciences and Clinical Research, 5(3). https://doi.org/10.37311/jsscr.v5i3.23723
Septia, A., Rahmalia, S., & Sabrian, F. (2018). Hubungan Dukungan Keluarga Dengan Kepatuhan Minum Obat Pada Penderita Tb Paru.
Sinjal, J., Wiyono, W., & Mpila, D. (2018). Identifikasi Drug Related Problems (Drps) Pada Pasien Congestive Heart Failure (Chf) Di Instalasi Rawat Inap Rsup Prof. Dr. R. D. Kandou Manado. In PHARMACON Jurnal Ilmiah Farmasi-UNSRAT (Vol. 7, Issue 4).
World Health Organization. (2016). Monitoring Health For The SDGS.
World Health Organization. (2022). Global Tuberculosis report 2022. http://apps.who.int/bookorders.
World Health Organization. (2024). Global Tuberculosis Report 2024.
Xi, Y., Zhang, W., Qiao, R. J., & Tang, J. (2022). Risk Factors For Multidrug-Resistant Tuberculosis: A Worldwide Systematic Review And Meta-Analysis. In PLoS ONE (Vol. 17, Issue 6 June). Public Library of Science. https://doi.org/10.1371/journal.pone.0270003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dizky R. Papeo, Tita Arikah Aulia, Siti Dinarti Husain, Selviana Selviana, Jhuandaniel Piator Pangaribuan, Alvionita B. Anwar

This work is licensed under a Creative Commons Attribution 4.0 International License.
Lontara Journal Of Health Science And Technology is licensed under Creative Commons.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International (CC BY 4.0).
The Creative Commons Attribution 4.0 International (CC BY 4.0) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.




